Bedfont to exhibit new and improved NObreath FeNO monitor at Arab Health 2019

Breath analysis medical device manufacturer, Bedfont, will be returning to Arab Health 2019 – the largest healthcare exhibition in the Gulf Cooperation Council. They will be exhibiting their wide range of breath analysis medical devices, including the new and improved NObreath® FeNO monitor.

NOBreath

Image credit: Bedfont Scientific

The NObreath® offers a quick, simple and non-invasive method of measuring FeNO to assess airway inflammation, aiding in the diagnosis and management of asthma.

Interpreting FeNO levels aids in identifying patients who do/do not require on-going treatment whilst also differentiating between allergic (eosinophilic) and non-allergic asthma, and if used daily, FeNO measurements can help to predict exacerbations and attacks.

Alongside a fresh and aesthetically pleasing design with a full-color touchscreen, new features of the 2nd generation NObreath® also include the ability to save patient profiles on the device, Bluetooth connectivity, and SteriTouch® technology for optimum infection control.

Furthermore, the NObreath® comes with free patient management software allowing the equipment to synchronize with a PC, enabling reports to be generated, data to be backed up, and much more.

Established in 1976, their other monitors include the Smokerlyzer®, used for smoking cessation, and the ToxCO®, used by emergency services, to screen for CO poisoning. The Gastrolyzer® range aids in the detection of gastrointestinal disorders and food intolerances.

Bedfont aims to continue improving and innovating health, and being the largest healthcare gathering in the GCC, Arab Health is the perfect place to find like-minded companies to work with and help raise awareness of the benefits of breath testing.”

Matthew Skinner, Sales Team Manager

This year, Arab Health is taking place between 28-31 January in Dubai and Bedfont can be found at stand C57, Hall 7.

Source: https://www.bedfont.com/news/home/bedfont-brings-the-2nd-generation-nobreath-to-the-gcc

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bedfont® Scientific Ltd. (2020, May 11). Bedfont to exhibit new and improved NObreath FeNO monitor at Arab Health 2019. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20190123/Bedfont-to-exhibit-new-and-improved-NObreath-FeNO-monitor-at-Arab-Health-2019.aspx.

  • MLA

    Bedfont® Scientific Ltd. "Bedfont to exhibit new and improved NObreath FeNO monitor at Arab Health 2019". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20190123/Bedfont-to-exhibit-new-and-improved-NObreath-FeNO-monitor-at-Arab-Health-2019.aspx>.

  • Chicago

    Bedfont® Scientific Ltd. "Bedfont to exhibit new and improved NObreath FeNO monitor at Arab Health 2019". News-Medical. https://www.news-medical.net/news/20190123/Bedfont-to-exhibit-new-and-improved-NObreath-FeNO-monitor-at-Arab-Health-2019.aspx. (accessed November 21, 2024).

  • Harvard

    Bedfont® Scientific Ltd. 2020. Bedfont to exhibit new and improved NObreath FeNO monitor at Arab Health 2019. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20190123/Bedfont-to-exhibit-new-and-improved-NObreath-FeNO-monitor-at-Arab-Health-2019.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sunshine and Steps for a Cause: Bedfont® Scientific’s Team Raise Vital Funds at Heart of Kent Hospice’s Bluebell Walk 2024.